Johnson & Johnson (JNJ) 101.08 $JNJ Lanny's Recent

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 12:40 PM

Johnson & Johnson (JNJ) 101.08 $JNJ

Lanny's Recent Purchase - Johnson & Johnson
Dividend Diplomats - Seeking Alpha - 27 mins ago
Phew… almost thought for a minute or a month there, that I may go a full 30 days without a right on stock purchase. Well, I guess I couldn't hold back for 30 days and have made a new stock purchase! Always having tricks up my sleeve and am...
JNJ: 101.08 (+0.62)

Final Glance: Pharmaceuticals companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Final Glance: Medical Devices companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

6 Stocks Pumping Up Their Yield With Increased Dividends
Dividends4Life - at Seeking Alpha - Fri Apr 24, 3:07PM CDT

JNJ: 101.08 (+0.62), RF: 9.58 (-0.04), COST: 148.12 (+0.82), WNR: 47.03 (+1.27), PG: 81.00 (+0.05), SO: 44.87 (+0.18)

Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)

CoLucid Pharmaceuticals on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 2:52PM CDT

AGN: 240.22 (+2.88), JNJ: 101.08 (+0.62), ENDP: 93.27 (-0.81), ALDR: 25.10 (-0.25), AVNR: 16.96 (unch), CLCD: (), RDHL: 14.70 (+0.02), PTX: 7.09 (-0.24), AMGN: 167.91 (-1.26), DEPO: 27.65 (+0.36), TEVA: 64.41 (+1.16), OFIX: 36.46 (+0.10)

Johnson & Johnson And Finicky Share Prices
Eli Inkrot - at Seeking Alpha - Fri Apr 24, 2:31PM CDT

JNJ: 101.08 (+0.62)

'Non-Cyclical Consumer Healthcare': How This Sector Will Create Long-Term Wealth
Peter Mantas - Seeking Alpha - Fri Apr 24, 1:39PM CDT
Allow me to provide you with a hypothetical portfolio containing only 5 stocks. This portfolio is somewhat diversified in that each company operates in different markets with different threats, competitors and opportunities, but all 5 companies have...
MCK: 229.20 (+0.09), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), EW: 138.33 (-3.59), LLY: 71.58 (-0.82), GSK: 46.59 (+0.28), MOH: 63.85 (-0.13), ORCL: 43.08 (-0.31), CNC: 73.67 (+1.13), JNJ: 101.08 (+0.62), ANTM: 154.28 (+0.08), VRSK: 72.68 (+0.20), GILD: 103.69 (-1.52), RMD: 65.70 (-7.68), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), FICO: 93.85 (+0.55), WCN: 46.52 (+0.32), SRCL: 136.94 (-3.56), SNY: 51.75 (-0.01), ACN: 93.40 (-0.44), NVS: 104.28 (-1.22)

Midday Glance: Pharmaceuticals companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Midday Glance: Medical Devices companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

Good Company Businesses Provide Balanced Portfolio
William Stamm - at Seeking Alpha - Fri Apr 24, 11:25AM CDT

JNJ: 101.08 (+0.62), HD: 113.70 (-0.26), LB: 91.20 (-0.45), DIS: 109.53 (+0.53), BA: 148.40 (-1.47)

High-Yield Placeholders For Dividend Champions
Fast Track to Financial Independence - at Seeking Alpha - Fri Apr 24, 10:29AM CDT

KO: 40.89 (-0.06), MMM: 158.99 (-0.67), HTGC: 13.97 (-0.09), MAIN: 31.39 (+0.09), SDIV: 24.18 (+0.22), ED: 62.50 (+0.40), TGH: 31.32 (unch), GSK: 46.59 (+0.28), BNS: 54.97 (-0.01), MORL: 20.47 (+0.08), STWD: 24.27 (+0.10), T: 34.01 (-0.22), JNJ: 101.08 (+0.62), OHI: 38.53 (+0.24), PFF: 40.05 (+0.01), PG: 81.00 (+0.05), AIG: 56.99 (+0.24), AAPL: 130.28 (+0.61), BBL: 47.75 (+1.40), GAIN: 7.56 (-0.03)

Early Glance: Pharmaceuticals companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Early Glance: Medical Devices companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

Illumina's Earnings Set Positive Tone for Biotech
Cheryl Swanson, The Motley Fool - Motley Fool - Fri Apr 24, 9:02AM CDT
Illumina just lit up a lot of biotech portfolios. Thanks to record-breaking shipments of gene-sequencing instruments, total quarterly revenue surged 28% to $539 million.. Despite facing currency headwinds, the company handily beat the $524.45...
JNJ: 101.08 (+0.62), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), AMGN: 167.91 (-1.26), ILMN: 189.59 (-3.01), SNY: 51.75 (-0.01)

Merck's HCV combo shows cure rates of 60 - 100% in three genotypes
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:05AM CDT

JNJ: 101.08 (+0.62), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82), BMY: 65.80 (-0.20)

Globus Medical elects Daniel Scavilla as SVP & CFO
M2 - Fri Apr 24, 5:43AM CDT
Musculoskeletal implant manufacturer Globus Medical (NYSE:GMED) revealed on Thursday the addition of Daniel T Scavilla as its senior vice president and chief financial officer with effect from 4 May 2015.
JNJ: 101.08 (+0.62), GMED: 24.79 (+0.15)

Johnson & Johnson Announces Dividend Increase of 7.1%
M2 - Fri Apr 24, 4:34AM CDT
Johnson & Johnson today announced that its Board of Directors has declared a 7.1% increase in the quarterly dividend rate, from $0.70 per share to $0.75 per share. The increase was announced this morning at the Annual Meeting of Shareholders in
JNJ: 101.08 (+0.62)

Johnson & Johnson to Host Pharmaceutical Business Review
M2 - Fri Apr 24, 4:27AM CDT
Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday, May 20, 2015 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m.
JNJ: 101.08 (+0.62)

Dale's Super 7 Dividend Aristocrat And Achievers Portfolio Core
Dale Roberts - at Seeking Alpha - Thu Apr 23, 5:45PM CDT

MMM: 158.99 (-0.67), GE: 26.80 (-0.05), MON: 118.46 (+0.97), NKE: 100.95 (-0.16), UTX: 116.16 (-1.10), BLK: 372.98 (+1.05), XOM: 86.97 (-0.57), WMT: 79.84 (+0.66), VIG: 81.59 (+0.22), PEP: 95.17 (-0.56), JNJ: 101.08 (+0.62), XLP: 49.19 (+0.01), SPY: 211.65 (+0.49), TRP: 47.13 (+0.12), IBM: 169.78 (-0.46), QCOM: 68.24 (-0.10), EOG: 96.72 (-1.55), LOW: 73.16 (-0.21), CAT: 84.60 (-0.19), OXY: 79.77 (-0.27), AAPL: 130.28 (+0.61), FDX: 169.95 (-0.15), KO: 40.89 (-0.06), ABT: 48.32 (-0.14), WBA: 85.98 (-0.71), MED: 31.52 (+0.25), TXN: 54.73 (+0.01), BCE: 44.92 (-0.03), CVS: 101.58 (+0.70), ENB: 53.83 (+0.12), AIG: 56.99 (+0.24), TU: 35.16 (-0.03), BRK.B: 142.09 (-0.34), CL: 69.17 (-0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Cultural Tech Fusion: The Asia-Pacific Way Forward

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

O-I Glass Faces Class Action: Investor Implications

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Onodrim Raises $300M to Propel EU Defence Future

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Tencent Cloud's Edge Platform Shines in New Gartner Report

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...